Readmission for Stroke and Quality of Care among Patients Hospitalized with Transient Ischemic Attack (TIA): Findings from Get With The Guidelines (GWTG)-Stroke.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Advertisements

© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
The Golden Hour and Acute Brain Ischemia: Presenting Features and Lytic Therapy in Over 30,000 Patients Arriving within 60 Minutes of Onset at GWTG-S.
Hernandez et al. JAMA, May 5, 2010 – Vol. 303, No. 17 Relationship Between Early Physician Follow-up and 30-day Readmission Among Medicare Beneficiaries.
Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Eric D.
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
IntroductionMethods (continued)Results (continued)Strengths and Limitations Background Pharmacologic treatments are efficacious in reducing post-myocardial.
DISCLOSURE INFORMATION (relative only): Eric D. Peterson, PI of the AHA GWTG Data Analysis Center; Lee H. Schwamm, Chair of the AHA National Steering Committee.
Guidelines recommend consideration of fibrinolytic therapy if unable to achieve a door to balloon time ≤120 minutes for STEMI patients transferred for.
Kelley M. Anderson, PhD, FNP
Emily O’Brien, MSPH Predoctoral Trainee February 16, 2010 The North Carolina Stroke Care Collaborative Clinical Outcomes among Stroke Patients Receiving.
“Influence of Stroke Subtype on Quality of Care in The Get With The Guidelines-Stroke Program” Eric E. Smith, MD, MPH; Li Liang PhD; Adrian F Hernandez,
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
Regional Differences in Quality of Care and Outcomes for the Treatment of Acute Coronary Syndromes: An Analysis from the Get With The Guidelines Program.
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained Over Time? A Longitudinal Comparison of GWTG-CAD.
Use of Hydralazine-Isosorbide Dinitrate combination in African American and Other Race/Ethnic Group Patients with Heart Failure and Reduced Ejection Fraction.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Quality of Care and In-Hospital Outcomes in Patients With Coronary Heart Disease in Rural and Urban Hospitals (from Get With the Guidelines– Coronary.
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,
Surveillance of Heart Diseases and Stroke Using Centers for Medicare and Medicaid (CMS) Data: A Researcher’s Perspective Judith H. Lichtman, PhD MPH Associate.
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Patients with HF have increased risk for thrombotic events. However, the net clinical benefit of anticoagulation in a HF population in sinus rhythm has.
The Long Term Multi-Center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation (RELY-ABLE) study To reviewers and moderators: These.
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality worldwide and in Singapore. In Singapore, there are about.
Schwamm et al. Circulation epub April 6Schwamm et al. Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke Lee H. Schwamm, MD; Mathew.
Background Using the GWTG-Stroke database and the Centers for Medicare & Medicaid Service files, we analyzed Medicare patients with acute ischemic stroke.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
ACTIVE Clopidogrel plus Aspirin versus Aspirin in Patients Unsuitable for Warfarin.
Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients: Results From the AHA’s Get With the Guidelines Program Todd M. Brown,
Influence of Age on the Management of Heart Failure: Findings from Get With the Guidelines-HF DE Forman, CP Cannon, AF Hernandez, L Liang, CW Yancy, GC.
1 Statin treatment is associated with improved prognosis in patients with AF-related stroke G. Ntaios, V. Papavasileiou, K.Makaritsis, A.Karagiannaki,
Global Variations in the 1-year Rates of Death and Stroke in Patients Presenting to the Emergency Department with Atrial Fibrillation Results from the.
Influence of Comorbid Depression and Antidepressant Treatment on Mortality for Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease by SSDI-eligibility.
Morbidity and Mortality in Contemporary CAD Patients With Hypertension Treated With Either a Verapamil/Trandolapril or Beta-Blocker/Diuretic Strategy (INVEST):
#735 KA Lichtenstein 1, C Armon 2, K Buchacz 3, AC Moorman 3, KC Wood 2, JT Brooks 3, and the HOPS Investigators 1 University of Colorado Health Sciences.
Background Current guideline recommend an early invasive strategy for NSTEMI patients (Class IIA). However, 67% US hospitals have no catheterization capability.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
Delays in Fibrinolytic Administration for Acute ST-Segment Elevation Myocardial Infarction: Results from the Acute Coronary Treatment and Interventions.
The Association between blood glucose and length of hospital stay due to Acute COPD exacerbation Yusuf Kasirye, Melissa Simpson, Naren Epperla, Steven.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
DR AMER JAFAR ‘STROKE’ October Ethnicity and recurrence of stroke Population-based study Compared poststroke recurrence and survival in Mexican.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The.
Presented by Renato D. Lopes, MD, PhD, Duke Clinical Research Institute, Duke University, USA for the ARISTOTLE investigators. Efficacy and Safety of Apixaban.
Impact of Prior Myocardial Infarction Among Patients with Acute Myocardial Infarction Treated in Contemporary Practice: A Report from the ACTION Registry.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal.
Management of Patients with NSTE ACS Latest Insights from CRUSADE A National Quality Improvement Initiative Eric D. Peterson, MD, MPH Duke Clinical Research.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Low-Dose Aspirin for Primary Prevention of Cardiovascular.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Angela Aziz Donnelly April 5, 2016
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Presentation transcript:

Readmission for Stroke and Quality of Care among Patients Hospitalized with Transient Ischemic Attack (TIA): Findings from Get With The Guidelines (GWTG)-Stroke Emily C. O’Brien 1, Xin Zhao 1, Gregg C. Fonarow 2, Eric E. Smith 3, Lee H. Schwamm 4, Deepak L. Bhatt 5, Ying Xian 1, Jeffrey L. Saver 2, Mathew J. Reeves 6, Eric D. Peterson 1, Adrian F. Hernandez 1 1 Duke Clinical Research Institute, Durham, NC; 2 Ronald-Reagan UCLA Medical Center, Los Angeles, CA; 3 Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada; 4 Massachusetts General Hospital, Harvard Medical School, Boston, MA; 5 VA Boston Medical Center, Harvard Medical School, Boston, MA; 6 Michigan State University, East Lansing, MI

Presenter Disclosure Information DISCLOSURE INFORMATION: Name: Emily O’Brien, PhD Title: Readmission for Stroke and Quality of Care among Patients Hospitalized with Transient Ischemic Attack (TIA): Findings from Get With The Guidelines (GWTG)- Stroke Disclosures: The American Heart Association and the American Stroke Association fund Get With The Guidelines-Stroke. The program has been supported in part by unrestricted educational grants to the American Heart Association by Pfizer, Inc., New York, NY, and the Merck-Schering Plough Partnership (North Wales, PA).

Background Transient Ischemic Attack (TIA) is associated with a markedly elevated risk for ischemic stroke Comprehensive risk prediction tools encompassing readily available variables may enhance identification of patients at risk for recurrent stroke Evidence-based management of TIA may reduce the risk of recurrent stroke The benefit of optimal clinical management in the context of underlying risk has not been fully explored

Objectives 1.Estimate risk of one-year admission for ischemic stroke after TIA hospitalization 2.Assess receipt of quality-of-care metrics by baseline readmission risk 3.Characterize the association between quality-of-care metrics provided during TIA hospitalization and one-year risk of ischemic stroke readmission

Hypotheses Patients with higher baseline ischemic stroke readmission risk are less likely to receive evidence-based care Receipt of evidence-based care is associated with lower rates of readmission for all baseline risk subgroups

Methods Data Sources –Get With The Guidelines-Stroke  Hospital-based quality improvement initiative  Trained personnel abstract demographic, clinical, and event information at participating sites –Probabilistic linkage to Medicare inpatient claims using indirect identifiers Study population –Starting population: N=108,527 TIA patients from 1326 GWTG sites –Exclusions:  Not linked to CMS data, or non-index records (N = 9145)  Transferred out, hospice, death, or no documented discharge destination (N =3471)  CMO (N = 435)  Not enrolled in Medicare FFS at hospital discharge (N = 4721)  Admitted after 2008 (N = 22,690)  CMS discharge date after 2008 (N = 173) –Final study population: N=58,809

GWTG Readmission Risk Score Predicted probability of readmission based on patient baseline characteristics –Demographics –Comorbidities Cox proportional hazards modeling with backwards selection (stay criterion of p=0.05) Discriminative performance of the model examined using c-statistics and ROC curves Patients categorized into quintiles of predicted readmission risk

Evidence-Based Care Individual –Antithrombotics by hospital day 2 –Anticoagulation for patients with atrial fibrillation –Antithrombotics at discharge –Lipid-lowering medications at discharge –Smoking cessation counseling Global –TIA defect-free care: receipt of all measures for which the patient was eligible

Outcomes –Primary  Hospitalization for ischemic stroke –Secondary  All-cause mortality

Statistical Analysis Baseline characteristics compared using Pearson Chi-squared and Wilcoxon rank sum tests Cox proportional hazards model to estimate risk for ischemic stroke readmission over one year in derivation cohort, with performance evaluation in validation cohort Censoring at death or loss of Medicare eligibility Cox models to estimate association between DFC and readmission within score quintiles

Baseline Characteristics (%) Variable Stroke Readmission within 1 year (N=3,318) No Stroke Readmission within 1 year (N=54,854) P-Value Age, median <.0001 Male gender Black Race <.0001 Prior stroke <.0001 CAD/Prior MI <.0001 Carotid stenosis Diabetes <.0001 PVD Hypertension Heart Failure3.42.3<.0001 Smoker Dyslipidemia <.0001 One-year risk of ischemic stroke hospitalization=5.7%

In-Hospital Quality Measures (%) Variable Stroke Readmission within 1 year (N=3,318) No Stroke Readmission within 1 year (N=54,854) P-Value Early Antithrombotics Discharge Antithrombotics Anticoagulants for AF Statin (LDL>100 or ND) Smoking Cessation Defect-Free Care † † Defect-free care=receipt of all TIA achievement measures for which the patient was eligible

GWTG 1-Year IS Readmission Risk Score Model VariableHazard Ratio95% CI Age (per 10 year increase) , 1.02 White Race , 0.86 Atrial Fibrillation/Flutter , 1.58 Previous Stroke/TIA , 1.55 CAD/Prior MI , 1.23 Diabetes Mellitus , 1.36 Smoking , 1.52 Dyslipidemia , 0.93 Arrival Mode (EMS vs. Other) , 1.28 Ambulate Independently at Discharge , 0.88 C-statistic=0.603

1-Year IS Readmission Overall 1-year Risk Death: 11.8% IS Readmission: 5.7% * ‡ GWTG Readmission for Stroke Risk Score estimated from age, gender, race, history of stroke/TIA, prosthetic heart valve, CAD/Prior MI, carotid stenosis, diabetes mellitus, PVD, hypertension, HF, smoker, dyslipidemia, hospital size, hospital type, and geographic region (c-statistic 0.59)

Results * ‡ GWTG Readmission for Stroke Risk Score estimated from age, gender, race, history of stroke/TIA, prosthetic heart valve, CAD/Prior MI, carotid stenosis, diabetes mellitus, PVD, hypertension, HF, smoker, dyslipidemia, hospital size, hospital type, and geographic region (c-statistic 0.59) % GWTG Readmission Risk Score Quintile

DFC and IS Readmission Unadjusted 1st2nd3rd4th5th GWTG Readmission Risk Quintile HR (95% CI)

Limitations Results may be influenced by residual confounding Information about medication use after discharge not available Percent of TIA patients admitted at each GWTG hospital not known DFC is a composite measure and appears to be driven largely by the statin use measure in this population Results may not be applicable to broader TIA patient population

Conclusions Patients who were readmitted for ischemic stroke within one year of TIA had a greater comorbidity burden than patients who were not readmitted TIA patients with a high baseline risk of readmission for IS are less likely to receive defect-free care than low-risk patients, largely due to lack of statin treatment Standardized risk assessment and delivery of optimal inpatient care for TIA may help to reduce this apparent risk-treatment mismatch

Acknowledgements The authors would like to thank the staff and participants of the GWTG-Stroke Registry for their important contributions to this work

Thank you

Candidate Risk Score Variables Age (per 10 year increase) Female Race (White vs. Other) Medical History of Atrial Fibrillation/Flutter Medical History of Prosthetic Heart Valve Medical History of Previous Stroke/TIA Medical History of CAD/Prior MI Medical History of Carotid Stenosis Medical History of Diabetes Mellitus Medical History of PVD Medical History of Hypertension Medical History of Smoking Medical History of Dyslipidemia Medical History of HF Academic Region – NE vs. W Region – MW vs. W Region – S vs. W

Risk Treatment Paradox Documented for heart failure and acute MI (possibly improving over time) Uncertainty about the risk: benefit ratio in patients at higher risk who are generally under-represented in randomized trials Information gaps in administrative datasets (i.e., lack of data on confounding clinical and functional variables that the clinician must weigh in making clinical decisions but which are not captured in administrative databases) Should also consider overutilization of nonevidence based therapies

ABCD2 Score -Validated for 2, 7, and 90 day IS but not long-term IS

Readmission Risk Prediction Meta-analysis of 26 unique risk-prediction models C-statistics: Two of five found that addition of functional or social variables improved discrimination Limitations include lack of information on hospital and systems-level factors, do not assess HRQOL, do not account for preventable readmissions JAMA. 2011;306(15):